Santiago Fontes, Medical Oncologist, Immuno-Oncology Specialist, shared a post on LinkedIn:
“Outstanding lecture by Prof. Heinz Josef Lenz in the Educational Session ASCO 2026
“Beyond RAS and RAF: proven and emerging targets in metastatic colorectal cancer.”
A compelling overview of how the therapeutic landscape in Metastatic Colorectal Cancer continues to evolve beyond canonical pathways, integrating validated molecularly driven strategies with a growing set of actionable targets. Discussion highlighted both the progress already reshaping clinical practice and the emerging directions that may further refine precision treatment in the near future.
A clear reminder that colorectal cancer biology is becoming increasingly actionable, moving well beyond traditional RAS/RAF-centric frameworks.”
